I just saw this even though it is from a few months ago - hope it is not a duplication on TIMS.
MedDay’s MD-1003 PHASE III Optic Neuritis Trial Results For MS
A clinical trial of MedDay’s promising medication MD-1003 in a study of the drugs impact on Optic Neuritis failed to meet its endpoint in outperforming placebo towards improving vision for people who have multiple sclerosis.
Here is a link to the article (from May 10, 2017 ):
http://www.msunites.com/meddays-md-1003 ... ts-for-ms/
On a positive note, they are reporting positive results for patients with Progressive Multiple Sclerosis (although only 12.6% of patients taking MD1003 (biotin) had an improvement in their EDSS score.)
MedDay’s Phase 3 Trial - impact on Optic Neuritis failed
Re: MedDay’s Phase 3 Trial - impact on Optic Neuritis failed
Dude,
Where do you get your stuff from? This is like 1 1/2 years old....
http://www.medday-pharma.com/news-and-e ... is-at-aan/
Where do you get your stuff from? This is like 1 1/2 years old....
http://www.medday-pharma.com/news-and-e ... is-at-aan/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 2 Replies
- 1060 Views
-
Last post by jimmylegs
-
- 0 Replies
- 11927 Views
-
Last post by NHE
-
- 0 Replies
- 2077 Views
-
Last post by frodo
-
- 0 Replies
- 1086 Views
-
Last post by frodo
-
- 2 Replies
- 1137 Views
-
Last post by frodo
-
- 0 Replies
- 1040 Views
-
Last post by NHE
-
- 0 Replies
- 1387 Views
-
Last post by NHE
-
- 0 Replies
- 1187 Views
-
Last post by frodo
-
- 0 Replies
- 1564 Views
-
Last post by NHE